BACE1 and Cognitive impairment: For example, MgT treatment was reported to stabilize β-secretase (BACE-1) expression and to reduce soluble APP and β-C-terminal fragments, which prevented and reversed cognitive deficits and synaptic loss in APP/PS1 transgenic mice (Li et al., 2014).